Apixaban Is Safe and Effective Thromboprophylaxis in Myeloma Patients Treated with Immunomodulatory Therapy
Publication details: 2017ISSN:- 00064971
- Blood
No physical items for this record
Serial
7124479
130
1
https://doi.org/10.1182/blood.V130.Suppl_1.1872.1872
Document_7124479_27363.pdf
There are no comments on this title.
Log in to your account to post a comment.